Poor
Not Aligned
Patient Risk:
Moderate
Summary
Most claims provided are general vaccine side-effect/timing and live-vaccine guidance that are not supported by the supplied COSENTYX label excerpts (which only cover infection/immune effects). The only clearly on-label theme within the provided label excerpts is that COSENTYX may increase infection risk/lower immune ability to fight infections; several claims about vaccination adverse events are therefore unsupported and un-auditable from the supplied label text.
Category Scores
Accurate Statements
After vaccination, side effects can come from the underlying medication’s effect on the immune system.
Supported generally by label theme that COSENTYX may lower ability to fight infections/raise infection risk (17; 5.1). However, the claim is broad and refers to vaccine side effects causality and immune effects without specifying infections.
Unsupported Statements
After vaccination, side effects can come from the vaccine itself.
No vaccine-side-effect mechanism, timing, or vaccine guidance is present in the supplied label excerpts.
Common vaccine side effects may include injection-site pain, redness, or swelling.
Not supported by the supplied COSENTYX label excerpts.
Common vaccine side effects may include fever or chills.
Not supported by the supplied COSENTYX label excerpts.
Common vaccine side effects may include tiredness (fatigue).
Not supported by the supplied COSENTYX label excerpts.
Common vaccine side effects may include headache.
Not supported by the supplied COSENTYX label excerpts.
Common vaccine side effects may include muscle aches.
Not supported by the supplied COSENTYX label excerpts.
Common vaccine side effects may include nausea.
Not supported by the supplied COSENTYX label excerpts.
These common vaccine side effects usually improve within a few days.
Not supported by the supplied COSENTYX label excerpts.
Live vaccines are generally avoided in patients taking biologic immune-modulating therapies.
No live/inactivated vaccine guidance is present in the supplied COSENTYX label excerpts.
If a live vaccine is given while on biologic immune-modulating therapy, it can pose safety risks compared with inactivated vaccines.
No live/inactivated vaccine safety comparison is present in the supplied COSENTYX label excerpts.
Symptoms consistent with a strong or prolonged reaction after vaccination may include high fever, severe headache, and worsening rash.
No vaccine reaction symptom guidance is present in the supplied COSENTYX label excerpts.
Signs of an allergic reaction after vaccination may include hives, facial swelling, and trouble breathing.
No vaccine allergic-reaction symptom guidance is present in the supplied COSENTYX label excerpts.
Seek urgent medical care after vaccination while on Cosentyx if there is trouble breathing, wheezing, or swelling of the face/lips/tongue.
No urgent-care triage instructions tied to vaccine administration are present in the supplied COSENTYX label excerpts.
Seek urgent medical care after vaccination while on Cosentyx if there is widespread hives.
No vaccine triage instructions tied to vaccine administration are present in the supplied COSENTYX label excerpts.
Seek urgent medical care after vaccination while on Cosentyx if there is severe or persistent fever, especially if it lasts more than a couple of days.
No vaccine fever-duration triage instructions are present in the supplied COSENTYX label excerpts.
Seek urgent medical care after vaccination while on Cosentyx if there is severe dizziness, fainting, or rapidly worsening symptoms.
No vaccine triage instructions tied to vaccine administration are present in the supplied COSENTYX label excerpts.
Most vaccine-related side effects start within about 24–48 hours of the shot.
Not supported by the supplied COSENTYX label excerpts.
Most vaccine-related side effects improve over the next 1–3 days.
Not supported by the supplied COSENTYX label excerpts.
Reactions that start later or last longer than expected should be discussed with a clinician, especially if the person is also taking Cosentyx.
Not supported by the supplied COSENTYX label excerpts.
Inactivated or non-live vaccines are generally preferred.
No vaccine type preference guidance is present in the supplied COSENTYX label excerpts.
Live vaccines are typically avoided during treatment with immune-modulating biologics like Cosentyx.
No live vaccine avoidance guidance is present in the supplied COSENTYX label excerpts.
Contact a healthcare provider promptly if a reaction is severe, getting worse, or lasting longer than a few days.
No general vaccine reaction prompt-contact instruction is present in the supplied COSENTYX label excerpts.
Contact a healthcare provider promptly if fever does not settle.
No fever-settling instruction related to vaccination is present in the supplied COSENTYX label excerpts.
Contact a healthcare provider promptly for any allergic-type symptoms.
No vaccine-allergy symptom prompt-contact instruction is present in the supplied COSENTYX label excerpts.
Contact a healthcare provider promptly if there is ongoing swelling or significant pain at the injection site.
No injection-site reaction prompt-contact instruction is present in the supplied COSENTYX label excerpts.
Contradictions
Important Omissions
On-label infection precautions specific to COSENTYX (e.g., instructing patients to seek medical advice for signs/symptoms of infection; monitor closely and discontinue until infection resolves; Hepatitis B reactivation counseling; not recommended for active viral hepatitis).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
While the response does not directly contradict the supplied COSENTYX infection/immune risk themes, it emphasizes many vaccine-specific side-effect and urgent-care instructions that are not supported by the provided label excerpts. It also omits COSENTYX-specific infection counseling and management instructions that are present in the supplied label text.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Majority of vaccine side-effect timing, symptom lists, and live vs inactivated vaccine guidance are not supported by the supplied COSENTYX label excerpts.
Suggested Improvement
Limit vaccination-related statements to what is supported by the COSENTYX FDA label text provided. If discussing immune/infection risk, align with label language that COSENTYX may increase risk of infections and lower immune ability, and instruct patients to contact a clinician for infection signs/symptoms (and include infection-management guidance such as monitoring and discontinuation until resolution as stated in the provided excerpts).